Logo

AutoGenomics Gets FDA Clearance for CYP2C19 Test, But Cannot Mention Plavix PGx

Oct 27, 2010
Premium

By Turna Ray

Already a GenomeWeb member? LoginLogin

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days

Benefits:
Full site access
Interest-based email alerts
Access to archives
Premium Access - Trial Offer
$95.00 for 3 month
Benefits:
Full site access
Interest-based email alerts
Access to archives

View all subscription optionsView all subscription options

Already a GenomeWeb member? LoginLogin

View all subscription optionsView all subscription options

Filed under

Diagnostics
Microarrays & Multiplexing
Companion Diagnostics
Cardiovascular Disease
heart disease
FDA
antiplatelet therapy
microarrays
Autogenomics
clopidogrel